|
1
|
Messerschmitt PJ, Garcia RM, Abdul-Karim
FW, Greenfield EM and Getty PJ: Osteosarcoma. J Am Acad OrthopSurg.
17:515–527. 2009. View Article : Google Scholar
|
|
2
|
Bousquet M, Noirot C, Accadbled F, Sales
de Gauzy J, Castex MP, Brousset P and Gomez-Brouchet A: Whole-exome
sequencing in osteosarcoma reveals important heterogeneity of
genetic alterations. Ann Oncol. 27:738–744. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mirabello L, Troisi RJ and Savage SA:
International osteosarcoma incidence patterns in children and
adolescents, middle ages and elderly persons. Int J Cancer.
125:229–234. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Miller BJ, Cram P, Lynch CF and Buckwalter
JA: Risk factors for metastatic disease at presentation with
osteosarcoma: An analysis of the SEER database. J Bone Joint Surg
Am. 95:e892013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ferrari S and Palmerini E: Adjuvant and
neoadjuvant combination chemotherapy for osteogenic sarcoma. Curr
Opin Oncol. 19:341–346. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Allison DC, Carney SC, Ahlmann ER,
Hendifar A, Chawla S, Fedenko A, Angeles C and Menendez LR: A
meta-analysis of osteosarcoma outcomes in the modern medical era.
Sarcoma. 2012:7048722012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lee RC and Ambros V: An extensive class of
small RNAs in Caenorhabditis elegans. Science. 294:862–864. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Friedman RC, Farh KK, Burge CB and Bartel
DP: Most mammalian mRNAs are conserved targets of microRNAs. Genome
Res. 19:92–105. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Irwandi RA and Vacharaksa A: The role of
microRNA in periodontal tissue: A review of the literature. Arch
Oral Biol. 72:66–74. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Vanas V, Haigl B, Stockhammer V and
Sutterlüty-Fall H: MicroRNA-21 increases proliferation and
cisplatin sensitivity of osteosarcoma-derived cells. PLoS One.
11:e01610232016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xia SS, Zhang GJ, Liu ZL, Tian HP, He Y,
Meng CY, Li LF, Wang ZW and Zhou T: MicroRNA-22 suppresses the
growth, migration and invasion of colorectal cancer cells through a
Sp1 negative feedback loop. Oncotarget. 8:36266–36278. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Qiao DD, Yang J, Lei XF, Mi GL, Li SL, Li
K, Xu CQ and Yang HL: Expression of microRNA-122 and microRNA-22 in
HBV-related liver cancer and the correlation with clinical
features. Eur Rev Med Pharmacol Sci. 21:742–747. 2017.PubMed/NCBI
|
|
13
|
Chen J, Wu FX, Luo HL, Liu JJ, Luo T, Bai
T, Li LQ and Fan XH: Berberine upregulates miR-22-3p to suppress
hepatocellular carcinoma cell proliferation by targeting Sp1. Am J
Transl Res. 8:4932–4941. 2016.PubMed/NCBI
|
|
14
|
Shankar J, Messenberg A, Chan J, Underhill
TM, Foster LJ and Nabi IR: Pseudopodial actin dynamics control
epithelial-mesenchymal transition in metastatic cancer cells.
Cancer Res. 70:3780–3790. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jaiswal JK, Lauritzen SP, Scheffer L,
Sakaguchi M, Bunkenborg J, Simon SM, Kallunki T, Jäättelä M and
Nylandsted J: S100A11 is required for efficient plasma membrane
repair and survival of invasive cancer cells. Nat Commun.
5:37952014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Woo T, Okudela K, Mitsui H, Tajiri M, Rino
Y, Ohashi K and Masuda M: Up-Regulation of S100A11 in lung
adenocarcinoma-its potential relationship with cancer progression.
PLoS One. 10:e01426422015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xiao MB, Jiang F, Ni WK, Chen BY, Lu CH,
Li XY and Ni RZ: High expression of S100A11 in pancreatic
adenocarcinoma is an unfavorable prognostic marker. Med Oncol.
29:1886–1891. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tian T, Hao J, Xu A, Hao J, Luo C, Liu C,
Huang L, Xiao X and He D: Determination of metastasis-associated
proteins in non-small cell lung cancer by comparative proteomic
analysis. Cancer Sci. 98:1265–1274. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Melle C, Ernst G, Schimmel B, Bleul A and
von Eggeling F: Colon-derived liver metastasis, colorectal
carcinoma, and hepatocellular carcinoma can be discriminated by the
Ca2+-binding proteins S100A6 and S100A11. PLoS One.
3:e37672008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Geng S, Gu L, Ju F, Zhang H, Wang Y, Tang
H, Bi Z and Yang C: MicroRNA-224 promotes the sensitivity of
osteosarcoma cells to cisplatin by targeting Rac1. J Cell Mol Med.
20:1611–1619. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gorlick R: Current concepts on the
molecular biology of osteosarcoma. Cancer Treat. Res. 152:467–478.
2009.
|
|
23
|
Bacci G, Briccoli A, Rocca M, Ferrari S,
Donati D, Longhi A, Bertoni F, Bacchini P, Giacomini S, Forni C, et
al: Neoadjuvant chemotherapy for osteosarcoma of the extremities
with metastases at presentation: Recent experience at the Rizzoli
Institute in 57 patients treated with cisplatin, doxorubicin, and a
high dose of methotrexate and ifosfamide. Ann Oncol. 14:1126–1134.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yu X, Li Z, Yu J, Chan MT and Wu WK:
MicroRNAs predict and modulate responses to chemotherapy in
colorectal cancer. Cell Prolif. 48:503–510. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Song B, Wang Y, Xi Y, Kudo K, Bruheim S,
Botchkina GI, Gavin E, Wan Y, Formentini A, Kornmann M, et al:
Mechanism of chemoresistance mediated by miR-140 in human
osteosarcoma and colon cancer cells. Oncogene. 28:4065–4074. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Martinez-Sanchez A, Dudek KA and Murphy
CL: Regulation of human chondrocyte function through direct
inhibition of cartilage master regulator SOX9 by microRNA-145
(miRNA-145). J Biol Chem. 287:916–924. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhu Z, Tang J, Wang J, Duan G, Zhou L and
Zhou X: MiR-138 acts as a tumor suppressor by targeting EZH2
and enhances cisplatin-induced apoptosis in osteosarcoma cells.
PLoS One. 11:e01500262016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hao J, Wang K, Yue Y, Tian T, Xu A, Hao J,
Xiao X and He D: Selective expression of S100A11 in lung cancer and
its role in regulating proliferation of adenocarcinomas cells. Mol
Cell Biochem. 359:323–332. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang LN, Tong SW, Hu HD, Ye F, Li SL, Ren
H, Zhang DZ, Xiang R and Yang YX: Quantitative proteome analysis of
ovarian cancer tissues using a iTRAQ approach. J Cell Biochem.
113:3762–3772. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sakaguchi M, Murata H, Sonegawa H,
Sakaguchi Y, Futami J, Kitazoe M, Yamada H and Huh NH: Truncation
of Annexin A1 is a regulatory lever for linking epidermal growth
factor signaling with cytosolic phospholipase A2 in
normal and malignant squamous epithelial cells. J Biol Chem.
282:35679–35686. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sakaguchi M, Miyazaki M, Takaishi M,
Sakaguchi Y, Makino E, Kataoka N, Yamada H, Namba M and Huh NH:
S100C/A11 is a key mediator of Ca2+-induced growth
inhibition of human epidermal keratinocytes. J Cell Biol.
163:825–835. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sakaguchi M, Sonegawa H, Murata H, Kitazoe
M, Futami J, Kataoka K, Yamada H and Huh NH: S100A11, an dual
mediator for growth regulation of human keratinocytes. Mol Biol
Cell. 19:78–85. 2008. View Article : Google Scholar : PubMed/NCBI
|
